, Columnist
So Much for Trump Going After Pharma
His executive order seems likely to be more of an industry wish list.
This article is for subscribers only.
President Donald Trump has gone from promising to bring down drug prices to looking like he's been captured by Big Pharma in just a few short months.
The president started out the year ripping into drugmakers and threatening to make firms bid for government business. Now? Rather than pushing for pricing legislation, his administration is reportedly settling for an executive order -- which, according to a Kaiser Health News report, may end up looking more like a pharma wish list than a menu of onerous demands.